SCHEMBL3883663

SCHEMBL3883663

COC(=O)CCc1ccc(OCC2CCCC2)c(-c2cnc3ccccc3c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 2/20 0.44
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
PTGER1 P34995 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41
PTPN1 P18031 2/20 0.41
TRPM5 Q9NZQ8 1/20 0.39
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
TRPV1 Q8NER1 1/20 0.38
ITGA4 P13612 1/20 0.38
ITGB7 P26010 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ABCB1 P08183 2/20 0.37
HCRTR1 O43613 1/20 0.37
HCRTR2 O43614 1/20 0.37
POLQ O75417 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3880639 0.99 C5AR1 (0.45) C5AR1MEN1KMT2APTGER1PTGDR2
SCHEMBL3884852 0.90 THRA (0.46) C5AR1MEN1KMT2APTGER1PTGDR2
SCHEMBL3882712 0.89 THRA (0.47) C5AR1MEN1KMT2APTGER1PTGDR2
SCHEMBL3893376 0.88 PPARG (0.41) C5AR1MEN1KMT2APTPN1CCNC
SCHEMBL3883719 0.87 CCNC (0.48) C5AR1MEN1KMT2APTGER1PTPN1
SCHEMBL7725141 0.85 C5AR1 (0.55) C5AR1MEN1KMT2APTGER1PTGDR2
SCHEMBL7725535 0.85 C5AR1 (0.57) C5AR1MEN1KMT2APTGER1PTPN1
SCHEMBL3889875 0.82 AKR1C3 (0.43) C5AR1MEN1KMT2APTGER1PTGDR2
SCHEMBL3687582 0.81 CCNC (0.44) C5AR1MEN1KMT2APTPN1CCNC
SCHEMBL3880637 0.81 C5AR1 (0.43) C5AR1MEN1KMT2APTGER1PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 C5AR1 282/4885MEN1 4756/4885KMT2A 2392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.